Enara Bio

Oxford, United Kingdom

Ervaxx is illuminating the immune interface to develop new cancer therapies.

$32.5M raised

Oct 2024

Series B

Top Investors

RA Capital ManagementSamsara BioCapitalPfizer Venture InvestmentsSV Health InvestorsM Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Enara Bio raised?

Enara Bio has raised $32.5M in total funding. The most recent round was Series B. The last funding was announced in October 2024.

Who are Enara Bio's investors?

Enara Bio's investors include RA Capital Management, Samsara BioCapital, Pfizer Venture Investments, SV Health Investors, M Ventures.

Where is Enara Bio headquartered?

Enara Bio is headquartered in Oxford, United Kingdom.

What does Enara Bio do?

Ervaxx is illuminating the immune interface to develop new cancer therapies.

What stage is Enara Bio at?

Enara Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 3, 2024.

MLA

"Enara Bio — Funding & Investors." VCBacked, October 3, 2024, https://www.vcbacked.co/company/enara-bio. Accessed July 1, 2026.

APA

VCBacked. (2024). Enara Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/enara-bio

Wikipedia (cite web)

{{cite web |title=Enara Bio — Funding & Investors |url=https://www.vcbacked.co/company/enara-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 3, 2024.